New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
TILT Holdings Inc.
TLLTF
Shape
US Flag

PNK

Unprofitable

Unprofitable

7M

Drug Manufacturers - Specialty & Generic

Next Earning date - 11 Nov 2024

7M

Drug Manufacturers - Specialty & Generic

Next Earning date - 11 Nov 2024

0.01USD
Shape0.00 ( 27.10%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-93%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

73%

Quote Panel

Shape
Updated October 22, 2024
1W 20.35 % 1M -1.09 % 3M -37.47 % 1Y -68.37 %

Key Metrics

Shape
  • Market Cap

    6.92M


  • Shares Outstanding

    508.49M


  • Share in Float

    468.10M


  • Dividende

    0


  • Earning Date

    11 Nov 2024


  • Price Target

    0.0136


  • Average Volume

    219682


  • Beta

    1.052


  • Range

    0.01-0.05


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.tiltholdings.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.03x

P/S Ratio

0.25x

P/B Ratio

3.8

Debt/Equity

-52.2%

Net Margin

$-0.2

EPS

How TLLTF compares to sector?

P/E Ratio

Relative Strength

Shape

TLLTF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$164M

Shape517%

2025-Revenue

$0.07

Shape19%

2025-EPS

$9M

Shape-235%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.04
vs -0.02

Q4.22

arrow
arrow

N/A

-0.19
vs -0.10

Q1.23

arrow
arrow

N/A

-0.01
vs -0.02

Q2.23

arrow
arrow

N/A

-0.07
vs -0.02

Q3.23

arrow
arrow

N/A

-0.02
vs -0.04

Q4.23

arrow
arrow

N/A

-0.06
vs -0.19

Q1.24

arrow
arrow

N/A

-0.02
vs -0.01

Q2.24

arrow
arrow

N/A

-0.09
vs -0.07

Q3.24

arrow
arrow

N/A

-0.03
vs -0.02

Q4.24

arrow
arrow

N/A

-0.03
vs -0.06

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-24%

40.5M  vs 53.4M

Q4.22

arrow
arrow

-18%

44.3M  vs 54.1M

Q1.23

arrow
arrow

0%

42.3M  vs 42.4M

Q2.23

arrow
arrow

-12%

41.6M  vs 47.1M

Q3.23

arrow
arrow

+10%

44.6M  vs 40.5M

Q4.23

arrow
arrow

-13%

38.6M  vs 44.3M

Q1.24

arrow
arrow

-12%

37.3M  vs 42.3M

Q2.24

arrow
arrow

-36%

26.6M  vs 41.6M

Q3.24

arrow
arrow

-39%

27.4M  vs 44.6M

Q4.24

arrow
arrow

-25%

29.1M  vs 38.6M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-8%

-0.08
vs -0.03

Q4.22

arrow
arrow

-60%

-0.60
vs -0.08

Q1.23

arrow
arrow

-4%

-0.04
vs -0.60

Q2.23

arrow
arrow

-29%

-0.29
vs -0.04

Q3.23

arrow
arrow

-10%

-0.10
vs -0.29

Q4.23

arrow
arrow

-36%

-0.36
vs -0.10

Q1.24

arrow
arrow

-18%

-0.18
vs -0.36

Q2.24

arrow
arrow

-212%

-2.12
vs -0.18

Institutionnal OwnershipShape

status-upQoQ

Q2.22

arrow
arrow

2

2
vs 2

NA

Q3.22

arrow
arrow

2

2
vs 2

NA

Q4.22

arrow
arrow

2

2
vs 2

NA

Q1.23

arrow
arrow

2

2
vs 2

NA

Q2.23

arrow
arrow

2

2
vs 2

NA

Q3.23

arrow
arrow

3

3
vs 2

50%

Q4.23

arrow
arrow

3

3
vs 3

NA

Q2.24

arrow
arrow

1

1
vs NA

NA

Earnings Growth

Latest News

TLLTF

globenewswire.com

16 hours ago